government backed digital currency Top

Argentine President Millay vowed to abolish capital and foreign exchange controls. Argentine President Millay promised to abolish capital and foreign exchange controls next year, and his government intends to negotiate a free trade agreement with the United States after Trump takes office. The difference between the black market exchange rate and the official exchange rate in Argentina has been narrowing, and even nearly disappeared in recent weeks, which helps the government to deregulate more easily. Millay announced that in order to solve the debt mountain problem of the central bank, Argentina will either sign a new agreement with the International Monetary Fund (IMF) to replace the existing $44 billion agreement or reach an agreement with private investors. "This brings us closer to the final abolition of capital control every day. Capital control is an abnormal phenomenon that should not have happened, and we will put a permanent end to it next year," Millay said in a national televised speech on Tuesday, accompanied by cabinet members. Millay said that from now on, Argentines will be allowed to pay, sell and earn income in any currency they want, but the peso will continue to be used for tax payment. Earlier on Tuesday, Millay said it would take four years to close the central bank, one of his main campaign promises.AI glasses concept stocks continued to rise, with Zhongke Lanxun, Hengxuan Technology and Mingyue Lens rising more than 12%, while Tianjian, Xingxing Technology, Yiyuan Communication, Yitong Communication and Zhuoyi Technology had previous daily limit. 

Private placement: Positive factors in the stock market are accumulating. Recently, A-shares have fluctuated, and the latest strategies of many first-line private placements for investment at the end of the year and the beginning of the year have been released one after another. A number of private placements are optimistic about the market at the end of the year. Kou Zhiwei, a partner of chongyang investment, said that the "strengthening unconventional countercyclical adjustment" proposed by the policy at the end of the year inspired market confidence. At present, compared with the end of September, the market has a large increase, and the market has fully expected and priced the policy overweight. The further rise of the short-term market may need the support of strong economic recovery data. Judging from the recent overall investment trends of private placement, the reporter found that maintaining medium and high positions and maintaining high flexibility of portfolios have become the strategic focus of current private placement institutions. (CSI)Tik Tok's concept change has increased the daily limit of the provincial broadcasting group, Tik Tok's concept change has increased, and the daily limit of the provincial broadcasting group, Aohai Technology, Gravity Media and 3D Communication has increased, and Tianlong Group, Haitian Ruisheng and Silk Road Vision have also increased.Vietnam Customs: The export volume of rice in November was 704,608 tons.

Offcn Education has set up a new company in Hainan with digital technology services. According to the enterprise survey APP, recently, Hainan Offcn Zhiyuan Education Technology Co., Ltd. was established, with Li Delin as the legal representative and a registered capital of 1 million yuan. Its business scope includes: enrollment assistance services; Digital technology services, etc. Enterprise survey shows that the company is indirectly wholly-owned by Zhonggong Education.According to a survey conducted by the Monetary Authority of Singapore, economists raised Singapore's GDP growth forecast from 2.6% to 3.6% in 2024.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.